Regenmed Development Organization
- Assets
- $3.2m
- Revenue
- $986.0k
- Investments
- $0.0
- Employees
- 0
- Location
- Winstonsalem, NC
- Founding
- 06/2005
- Data as of
- 12/2022
- EIN
- 20-2710571
Organization Overview
Regenmed Development Organization is located in Winstonsalem, NC. The organization was established in 2005. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Regenmed Development Organization is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Regenmed Development Organization generated $986.0k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 6 years, the organization has seen revenues fall by an average of (9.2%) each year. All expenses for the organization totaled $1.0m during the year ending 12/2022. As we would expect to see with falling revenues, expenses have declined by (9.1%) per year over the past 6 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2019, Regenmed Development Organization has awarded 14 individual grants totaling $7,573,056. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
ADVANCING REGENERATIVE MEDICINE TECHNOLOGIES
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE REGENMED DEVELOPMENT ORGANIZATION (REMDO) CONDUCTS RESEARCH TO DE-RISK TECHNOLOGIES AND SPEED UP THE TRANSLATION OF REGENERATIVE MEDICINE TECHNOLOGIES TO CLINICAL PRACTICE. REMDO WAS AWARDED FUNDING FOR PROJECTS AIMED AT ACCELERATING MANUFACTURING INNOVATION FOR REGENERATIVE MEDICINE PRODUCTS. REMDO HAS ASSEMBLED A CONSORTIUM COMPRISED OF WORLD CLASS LEADERS IN REGENERATIVE MEDICINE RESEARCH AND DEVELOPMENT, BOTH COMMERCIAL AND ACADEMIC, TO EXECUTE ON ADVANCED BIOMANUFACTURING INITIATIVES. THE FUNDING WAS RECEIVED FROM THE MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM, A DEPARTMENT OF DEFENSE-FUNDED NONPROFIT ENTITY FORMED TO CONDUCT RESEARCH AND PROTOTYPING TO SUPPORT THE US ARMY MEDICAL RESEARCH AND MATERIEL COMMAND.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Anthony Atala MD Chair | OfficerTrustee | 0.5 | $0 |
J Reid Morgan Director & Asst Secretary | OfficerTrustee | 0.1 | $0 |
Terry L Hales Jr Vice Chair & Treasurer | OfficerTrustee | 0.1 | $0 |
Terry G Williams Director | Trustee | 0.1 | $0 |
Julie M Watson Director & Secretary | OfficerTrustee | 0.5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $985,996 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $985,996 |
| Total Program Service Revenue | $0 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $985,996 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $836,117 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $17,803 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $56,175 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $16,229 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $45,931 |
| Advertising and promotion | $0 |
| Office expenses | $1,671 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $10,661 |
| Insurance | $0 |
| All other expenses | $33,021 |
| Total functional expenses | $1,017,608 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $2,860,291 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $346,263 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $3,206,554 |
| Accounts payable and accrued expenses | $3,226,722 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $3,226,722 |
| Net assets without donor restrictions | -$20,168 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $3,206,554 |
Grants Awarded
Over the last fiscal year, Regenmed Development Organization has awarded $836,117 in support to 3 organizations.
| Grant Recipient | Amount |
|---|---|
WAKE FOREST UNIVERSITY HEALTH SCIENCES PURPOSE: RESEARCH SUB AWARD FOR TRANSLATIONAL REGENERATIVE MEDICINE PROJECTS | $718,185 |
WILLIAM MARSH RICE UNIVERSITY PURPOSE: RESEARCH SUB AWARD FOR SUPPORTING DEVELOPMENT OF UNIVERSAL BIOINK FORMULATIONS | $44,802 |
UNIVERSITY OF OREGON PURPOSE: RESEARCH SUB AWARD FOR SUPPORTING DEVELOPMENT OF UNIVERSAL MEDIA | $73,130 |